Back to Business

Teva: 'Hold' On FDA Approval Of Weltruza And Pivot To Growth Strategy

Business October 9, 2026 at 8:55 PM

Teva: 'Hold' On FDA Approval Of Weltruza And Pivot To Growth Strategy

Seeking Alpha

Read the full story at Seeking Alpha

More Stories

Depreciation Subtleties: S&P Earnings Are Vastly Overstated

Depreciation Subtleties: S&P Earnings Are Vastly Overstated

🇺🇸 Seeking Alpha 27m ago

Hershey Trust Co sells $3.25 million in Hershey Co shares

Hershey Trust Co sells $3.25 million in Hershey Co shares

🇺🇸 Investing.com 31m ago

Lockheed Martin unveils PAC-3 Edge interceptor designed to counter hypersonic threats

Lockheed Martin unveils PAC-3 Edge interceptor designed to counter hypersonic threats

🇺🇸 Investing.com 34m ago

Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play